| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Technical Officer | SVP, Chief Technical Officer
1 company
Labarre Michael J. is a SVP, Chief Technical Officer at HALOZYME THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $12.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 2,878 | $49.26 | $141,770.28 | -1.9% | -32.1% | -26.7% | |
| Feb 15, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 10,000 | $48.39 | $483,940.00 | -6.5% | -32.3% | -27.0% | |
| Jan 17, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 10,000 | $50.46 | $504,590.17 | -3.4% | -29.4% | -29.4% | |
| Dec 13, 2022 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 10,000 | $58.67 | $586,674.55 | -3.1% | -27.2% | -28.6% | |
| Nov 15, 2022 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 10,000 | $54.13 | $541,263.11 | -2.0% | -9.1% | -27.2% | |
| Oct 1, 2021 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 29,450 | $39.93 | $1,175,967.95 | -16.5% | -1.1% | -3.0% | |
| Jul 1, 2021 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 40,315 | $45.70 | $1,842,314.87 | -23.1% | -14.5% | -4.1% | |
| Apr 1, 2021 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 28,689 | $42.56 | $1,221,037.21 | -9.8% | +7.0% | -1.9% | |
| Mar 1, 2021 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 18,324 | $45.81 | $839,363.62 | -6.8% | - | - | |
| Dec 21, 2020 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 12,000 | $42.58 | $510,918.60 | -4.6% | - | - |